Cargando…

A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study

SIMPLE SUMMARY: Systemic therapies for advanced biliarty tract cancers (BTC) are limited. The combination of gemcitabine with cisplatin (GC) has been the standard first-line treatment for advanced BTC from 2010 until now. In order to improve therapeutic effect, especially response rate, we added a n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Sung-Nan, Liao, Chun-Kai, Chen, Yaw-Sen, Tseng, Cheng-Hao, Hung, Chao-Ming, Chiu, Chong-Chi, Hsieh, Meng-Che, Tsai, Yu-Fen, Liao, Hsiu-Yun, Liu, Wei-Ching, Rau, Kun-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345065/ https://www.ncbi.nlm.nih.gov/pubmed/34359732 http://dx.doi.org/10.3390/cancers13153831

Ejemplares similares

Metronomic vinorelbine is an excellent and safe treatment for advanced breast cancer: a retrospective, observational study
por: Liu, Chien-Ting, et al.
Publicado: (2021)

S-1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis
por: Hsieh, Meng-Che, et al.
Publicado: (2020)

Chemotherapy for Biliary Tract Cancer in 2021
por: Sasaki, Takashi, et al.
Publicado: (2021)

IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer
por: Hack, Stephen P., et al.
Publicado: (2021)

Guidelines for chemotherapy of biliary tract and ampullary carcinomas
por: Furuse, Junji, et al.
Publicado: (2008)

A Prognostic Model Using Inflammation- and Nutrition-Based Scores in Patients With Metastatic Gastric Adenocarcinoma Treated With Chemotherapy
por: Hsieh, Meng-Che, et al.
Publicado: (2016)

mTOR Inhibitors in Advanced Biliary Tract Cancers
por: Wu, Chao-En, et al.
Publicado: (2019)

Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
por: Bonet Beltrán, Marta, et al.
Publicado: (2011)

Current progress in perioperative chemotherapy for biliary tract cancer
por: Ioka, Tatsuya, et al.
Publicado: (2023)

Integrin αIIbβ3 outside-in signaling activates human platelets through serine 24 phosphorylation of Disabled-2
por: Tsai, Hui-Ju, et al.
Publicado: (2021)

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
por: Harder, J, et al.
Publicado: (2006)

Current status of chemotherapy for the treatment of advanced biliary tract cancer
por: Sasaki, Takashi, et al.
Publicado: (2013)

An Assessment of Combination of the Camrelizumab With Chemotherapy in Metastatic Biliary Tract Cancers
por: Yu, Yi, et al.
Publicado: (2021)

Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Safety and Effectiveness of Chemotherapy in Elderly Biliary Tract Cancer Patients
por: Okamoto, Takeshi, et al.
Publicado: (2023)

Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study
por: Wang, Kang, et al.
Publicado: (2023)

Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer
por: Thol, Felix, et al.
Publicado: (2021)

Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review
por: Wang, Yaoqun, et al.
Publicado: (2023)

Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes
por: Tseng, Chin-Hsiao
Publicado: (2020)

Influence of the Biliary System on Biliary Bacteria Revealed by Bacterial Communities of the Human Biliary and Upper Digestive Tracts
por: Ye, Fuqiang, et al.
Publicado: (2016)

High expression of endoglin in primary breast cancer may predict response to neoadjuvant chemotherapy
por: Rau, Kun-Ming, et al.
Publicado: (2017)

Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer
por: Chiang, Nai-Jung, et al.
Publicado: (2016)

Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis
por: Bai, Xue-Song, et al.
Publicado: (2022)

Bevacizumab combined with chemotherapy for ovarian cancer: A protocol for systematic review and meta-analysis
por: Liao, Ting, et al.
Publicado: (2021)

Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials
por: Eckel, F, et al.
Publicado: (2007)

Quality of life across chemotherapy lines in patients with cancers of the pancreas and biliary tract
por: Zabernigg, August, et al.
Publicado: (2012)

Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer
por: Kim, Hyera, et al.
Publicado: (2020)

Chemotherapy for biliary tract cancer: real-world experience in a single institute
por: Maeda, Osamu, et al.
Publicado: (2020)

Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
por: Wu, Chiao-En, et al.
Publicado: (2020)

BILIARY TRACT DISORDERS
Publicado: (1984)

Therapeutic Effect and Prognosis of Biliary Tract Tumor Transformation
por: Shang, PeiPei, et al.
Publicado: (2022)

Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy
por: Wu, Chiao-En, et al.
Publicado: (2021)

A preliminary randomised controlled study of short-term Antrodia cinnamomea treatment combined with chemotherapy for patients with advanced cancer
por: Tsai, Ming-Yen, et al.
Publicado: (2016)

SPAK Deficiency Attenuates Chemotherapy-Induced Intestinal Mucositis
por: Huang, Tien-Yu, et al.
Publicado: (2021)

Medium-term surgical outcomes and health-related quality of life after laparoscopic vs open colorectal cancer resection: SF-36 health survey questionnaire
por: Hung, Chao-Ming, et al.
Publicado: (2023)

Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors
por: Zhang, Zhengfeng, et al.
Publicado: (2023)

Preoperative biliary drainage for biliary tract and ampullary carcinomas
por: Nagino, Masato, et al.
Publicado: (2008)

Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer
por: Ito, Zensho, et al.
Publicado: (2022)

Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
por: Fornaro, L, et al.
Publicado: (2014)

Chemotherapy for advanced biliary tract carcinoma: A meta-analysis of randomized controlled trials
por: Chen, Lawrence, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bjr65cbgh6orek30volljqhfdq